This website uses cookies to ensure you get the best experience on our website. Privacy Policy
UroToday UroToday
  • Contact
  • Login
  • Sign Up Free
  • Transformative Evidence
    • mCRPC
      • The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
      • PROfound
      • VISION Trial
    • mHSPC
      • ARASENS Trial
    • nmCRPC
      • ARAMIS Trial
    • PSMA PET Imaging
      • CONDOR Trial
      • OSPREY Trial
    • Bladder Cancer
      • Bladder Cancer Detection
  • Trials in Progress
    • Trials in Progress
      • Bladder Cancer
        • IMMORTAL
      • Kidney Cancer
        • RadiCal
    • Middle Side
      • Prostate Cancer
        • ARAMON
        • ARASEC
        • ARASTEP
        • ECLIPSE
        • FORT
        • NRG-GU 0101
        • Masofaniten (Oral EPI-7386)
        • RTIRE
        • SHORTER
        • SPLASH
    • Right Side
      • PCCTC
        • DORA
        • IRONMAN
        • PROMISE
  • Centers of Excellence
    • Urologic Oncology
      • Left Group
        • Health Policy
          • Health Policy
            Ruchika Talwar, MD
        • Bladder Cancer
          • Bladder Cancer
            Ashish Kamat, MD
          • Advanced Bladder Cancer
            Petros Grivas, MD
          • Trimodality Therapy
            Leslie Ballas, MD
        • Kidney Cancer
          • Advanced Kidney Cancer
            Pedro Barata, MD, MSc
          • Kidney Cancer Today
            Sumanta (Monty) Kumar Pal, MD
            Jaime Landman, MD
      • Prostate Cancer
        • Advanced Prostate Cancer
          Alicia Morgans, MD, MPH
        • CRPC with Bone Metastases
          Rana R. McKay, MD
        • Imaging Center
          Phillip Koo, MD
        • Localized Prostate Cancer
          Matthew R. Cooperberg, MD, MPH
        • mHSPC
          Alicia Morgans, MD, MPH
        • nmCRPC
          Alicia Morgans, MD, MPH
        • PSMA-Targeted Therapy
      • Disparities: Social Determinants of Health
        • Disparities: Social Determinants of Health
          Samuel L. Washington III, MD, MAS
      • Translational Prostate Cancer
        • Translational Science in Prostate Cancer
          Andrea Miyahira, Ph.D
        • Women in Science
          Andrea Miyahira, Ph.D
      • Upper Tract Urothelial Carcinoma
        • Upper Tract Urothelial Carcinoma
          Sam S. Chang, MD, MBA
      • TESTICULAR, PENILE & RARE GU MALIGNANCIES
        • Testicular, Penile, and Rare GU Malignancies
    • Pelvic Health & Reconstruction
      • Bladder Health
        Diane K. Newman, DNP, ANP-BC, FAAN
      • Pelvic Health
        Diane K. Newman, DNP, ANP-BC, FAAN
      • Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
        Stephen R. Kraus, MD
      • Urologic Catheters (Includes CAUTI)
        Diane K. Newman, DNP, ANP-BC, FAAN
      • Suprapubic Catheter
        Diane K. Newman, DNP FAAN BCB-PMD
  • Videos
    • Exclusives
      • Conferences
      • Exclusive Collaborations
      • Independent Medical Education
      • Covid-19
      • The Prostate Cancer Foundation
    • Urologic Oncology
      • Prostate Cancer
      • Bladder Cancer
      • Kidney Cancer
      • Upper Tract Urothelial Tumors
      • Pelvic Health & Reconstruction
      • Endourology
      • Testicular Cancer
      • Health Policy in Urological Diseases
      • Disparities: Social Determinants of Health
  • Clinical Trials
    • From the Editor
      • Search Clinical Trials
  • Articles
    • Urology (benign and malignant)
      • Urologic Oncology
      • Men's Health
      • Endourology & Stones
      • Pediatric Urology
      • COVID-19 and Genitourinary Cancers
    • Pelvic Health
      • Pelvic Health & Reconstruction
  • Conference Coverage
    • Recent Conferences
      • ASTRO 2023
      • SNMMI 2023
      • ProsTIC/PCF Global Webinar 2023
      • ASCO 2023
      • AUA 2023
    • All Conferences
      • View All
  • PCF
  1. UroToday Home
  2. Recent Abstracts
  3. Urologic Oncology
  4. Bladder Cancer

Conferences

Recent Abstracts
GU Cancers Symposium 2013 - Novel strategies for targeting the androgen-receptor axis: PARP1 as a mediator of androgen receptor-dependent transcriptional control, by Karen E. Knudsen, PhD - Session Highlights February 15, 2013
GU Cancers Symposium 2013 - Clinical trial design strategies in the post-abiraterone/enzalutamide setting, by Charles J. Ryan, MD, UCSF - Session Highlights February 15, 2013
GU Cancers Symposium 2013 - What tools are available to aid in the use of active surveillance? The imaging perspective - Session Highlights February 15, 2013
GU Cancers Symposium 2013 - High-risk prostate cancer treated with pelvic radiotherapy and 36 vs 18 months of androgen blockade: Results of a phase III randomized trial - Slide Presentation February 15, 2013
GU Cancers Symposium 2013 - Updated analysis of radium-223 dichloride impact on skeletal-related events (SRE) in patients with castration-resistant prostate cancer (CRPC) and bone metastases from the phase 3 randomized trial (ALSYMPCA) - Poster February 15, 2013
GU Cancers Symposium 2013 - Additional Noteworthy Research to be Presented at the 2013 Genitourinary Cancers Symposium February 14, 2013
GU Cancers Symposium 2013 - Active Surveillance- Intelligent PSA Testing February 14, 2013
GU Cancers Symposium 2013 - Improving active surveillance: The emerging role of biomarkers February 14, 2013
GU Cancers Symposium 2013 - The pathology perspective on available tools for active surveillance February 14, 2013
GU Cancers Symposium 2013 - The imaging perspective on available tools for active surveillance February 14, 2013
GU Cancers Symposium 2013 - Hospital readmission following cystectomy is associated with omission of post-operative chemotherapy in patients with urothelial carcinoma of the bladder - Overview by Marc Smaldone, MD, Fox Chase Cancer Center, PA February 14, 2013
GU Cancers Symposium 2013 - Treatment and surveillance of prostate cancer patients - Symposium Summary February 14, 2013
Landmark survey of prostate biopsies confirms sampling standard February 14, 2013
Research from the 2013 Genitourinary Cancers Symposium highlights new insights on high-risk prostate cancer prevalence and treatment, compares benefit of surveillance and surgery for management of small kidney tumors February 13, 2013
Key research from the 2013 Genitourinary Cancers Symposium to be featured in February 12 presscast January 8, 2013
SIU 2012 - IYUA Symposium: The importance of mentorship and role models in urology - Slide Presentation October 27, 2012
SIU 2012 - How to build and grow your practice in Asia - Slide Presentation October 11, 2012
AUGS 2012 - A pilot study evaluation of vaginal mesh palpability and de novo dyspareunia after trans-vaginal mesh placement - Session Highlights October 10, 2012
AUGS 2012 - Ultra lightweight polypropylene "Y" graft for robotic assisted sacrocolopopexy (RASC): Retrospective anatomic and functional outcomes - Session Highlights October 10, 2012
AUGS 2012 - The prevalence of urinary incontinence among community dwelling women: Results from the National Health and Nutrition Examination Survey (NHANES), 2001-2008 - Session Highlights October 5, 2012
Page 503 of 524
  • Start
  • Prev
  • 498
  • 499
  • 500
  • 501
  • 502
  • 503
  • 504
  • 505
  • 506
  • 507
  • Next
  • End
  • About UroToday
  • Journals
  • Calendar
  • Editorial and Advertising Guidelines
  • Editors and Contributors
  • FAQs
  • Privacy Policy
  • Terms of Use
Follow UroToday

COPYRIGHT © 2002 - 2023 DIGITAL SCIENCE PRESS, LLC

Login

Login to update email address, newsletter preferences and use bookmarks.

  • Forgot Password?
  • Sign Up Free